Free Trial

TerrAscend (OTCMKTS:TRSSF) Trading 35.2% Higher - Time to Buy?

TerrAscend logo with Medical background

Key Points

  • TerrAscend Corp. stock surged 35.2% to $0.75 during trading, significantly higher than its previous close of $0.55.
  • Trading volume reached approximately 3 million shares, a striking increase of 2,215% compared to the average daily volume.
  • The company is involved in the cultivation and sale of medical and adult-use cannabis, along with hemp-derived wellness products and cannabis-infused edibles.
  • MarketBeat previews top five stocks to own in October.

TerrAscend Corp. (OTCMKTS:TRSSF - Get Free Report) shot up 35.2% during trading on Tuesday . The company traded as high as $0.77 and last traded at $0.75. 3,033,571 shares traded hands during mid-day trading, an increase of 2,215% from the average session volume of 131,026 shares. The stock had previously closed at $0.55.

TerrAscend Stock Performance

The business has a 50 day moving average price of $0.38 and a 200 day moving average price of $0.41. The company has a quick ratio of 0.40, a current ratio of 0.73 and a debt-to-equity ratio of 0.55.

TerrAscend Company Profile

(Get Free Report)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey.

Featured Stories

Should You Invest $1,000 in TerrAscend Right Now?

Before you consider TerrAscend, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.

While TerrAscend currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.